Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
13 12 Search
2024
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review
Critical Reviews in Oncology/Hematology
2024
Clinicopathological risk factors for prognosis and therapeutic response of primary central nervous system lymphoma in China: a single-center retrospective analysis of 118 cases
Annals of Hematology
2024
SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data
Computer Methods and Programs in Biomedicine
2023
Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: A review
Medicine
2023
Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma
Frontiers in Immunology
2023
Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B‐cell lymphoma
Cancer Medicine
2022
Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein–Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma
Frontiers in Genetics
2022
Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
Journal of Translational Medicine
2021
Expression of N 6 -methyladenosine (m 6 A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL)
Bioengineered
2021
Implication of immune cell signature of tumor microenvironment in diffuse large B‐cell lymphoma
Hematological Oncology
2021
The use of tafasitamab in diffuse large B-cell lymphoma
Therapeutic Advances in Hematology
Additional cited-by details will be shown when available from Crossref